MoneyWorks4Me

Biocon informs about press release

15 Feb 2016 Evaluate

Biocon has informed about a Press Release dated February 15, 2016 titled ‘Biocon Gets its First Generic Formulation Approval in EU; On Track to Launch Rosuvastatin Tablets in FY 17’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1775.40
Dr. Reddys Labs. 1182.05
Cipla 1328.95
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..